Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for EVHO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 -0.0219M
March 31, 2026 0.0107M
December 31, 2025 0.1034M
September 30, 2025 -0.0064M
June 30, 2025 -0.0011M
March 31, 2025 -0.0013M
September 30, 2024 -0.0479M
June 30, 2024 0.0709M
March 31, 2024 -0.8443M
December 31, 2023 -0.3633M
September 30, 2023 0.5565M
June 30, 2023 -0.3697M
March 31, 2023 -0.2155M
December 31, 2022 -0.3524M
September 30, 2022 -0.548M
June 30, 2022 -0.9529M
March 31, 2022 -0.6906M
December 31, 2021 0.0693M
September 30, 2021 -0.8291M
June 30, 2021 -0.4515M
March 31, 2021 -1.718M
December 31, 2020 -0.509M
September 30, 2020 -0.2803M
June 30, 2020 -0.3703M
March 31, 2020 -0.2842M
Date Value
December 31, 2019 -0.5605M
September 30, 2019 -0.3652M
June 30, 2019 -0.2202M
March 31, 2019 -0.2924M
December 31, 2018 -0.3376M
September 30, 2018 -0.0353M
June 30, 2018 -0.0619M
March 31, 2018 -0.05M
December 31, 2017 0.1571M
September 30, 2017 -0.0488M
June 30, 2017 -0.0893M
March 31, 2017 -0.1079M
December 31, 2016 -0.0335M
September 30, 2016 -0.0427M
June 30, 2016 -0.0364M
March 31, 2016 -0.062M
December 31, 2015 -0.0121M
September 30, 2015 -0.0164M
June 30, 2015 -0.0164M
March 31, 2015 -0.105M
September 30, 2014 -0.0034M
June 30, 2014
March 31, 2014
December 31, 2012 0.00
September 30, 2012 0.2889M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
BioForce Nanosciences Holdings, Inc. -0.027M
DND Technologies, Inc. --
Skinhealth Systems, Inc. 1.466M
Bonk, Inc. -2.226M
Upexi, Inc. -3.718M